MEN — Molecular Energies Income Statement
0.000.00%
- £0.87m
- £36.05m
- $31.55m
- 15
- 85
- 13
- 27
Annual income statement for Molecular Energies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 47.2 | 40.8 | 27.8 | 34.1 | 31.5 |
Cost of Revenue | |||||
Gross Profit | 14.7 | 4.98 | -3.92 | 1.47 | 4.08 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 35.8 | 130 | 38.2 | 37.9 | 40.1 |
Operating Profit | 11.4 | -89.1 | -10.5 | -3.76 | -8.53 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.08 | -93.6 | -10.3 | 5.7 | -9.04 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.12 | -88.3 | -11.3 | 4.58 | -7.07 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.12 | -88.3 | -11.3 | 4.58 | -10.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.12 | -88.3 | -11.3 | 4.58 | -10.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.291 | -5.34 | -1.21 | 0.406 | -0.17 |